Literature DB >> 3027054

The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation.

K Ueda, D P Clark, C J Chen, I B Roninson, M M Gottesman, I Pastan.   

Abstract

Multidrug resistance in human KB carcinoma cells selected for resistance to colchicine, vinblastine, or adriamycin results from overexpression, and frequently amplification, of a specific gene (mdr1). Overlapping cDNA clones representing a complete 4.7-kilobase mdr1 transcript have been obtained from multidrug-resistant KB cells. Primer extension and S1 nuclease protection experiments show that two transcripts initiate 136 and 140 bases upstream from the first ATG codon in all human multidrug-resistant cell lines. The mdr1 gene is expressed in human normal kidney cells and HepG2 liver cells as a poly(A)+ RNA which starts from the same sites. Less prominent transcripts were found to initiate 155-180 bases upstream from the first ATG codon in vinblastine- or adriamycin-selected cell lines and 480-630 bases upstream in colchicine-selected cell lines. Southern hybridization analyses with different portions of a full-length cDNA indicate that the human mdr1 gene encompasses at least 70 kilobases of DNA amplified in all highly multidrug-resistant cell lines.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3027054

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  93 in total

1.  MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects.

Authors:  T Sakaeda; T Nakamura; M Horinouchi; M Kakumoto; N Ohmoto; T Sakai; Y Morita; T Tamura; N Aoyama; M Hirai; M Kasuga; K Okumura
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

Review 2.  Drug resistance: still a daunting challenge to the successful treatment of AML.

Authors:  Brian C Shaffer; Jean-Pierre Gillet; Chirayu Patel; Maria R Baer; Susan E Bates; Michael M Gottesman
Journal:  Drug Resist Updat       Date:  2012-03-11       Impact factor: 18.500

3.  Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries.

Authors:  S P Ho; D H Britton; B A Stone; D L Behrens; L M Leffet; F W Hobbs; J A Miller; G L Trainor
Journal:  Nucleic Acids Res       Date:  1996-05-15       Impact factor: 16.971

Review 4.  Molecular mechanisms of drug resistance.

Authors:  J D Hayes; C R Wolf
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

5.  Structural analysis of the mouse mdr1a (P-glycoprotein) promoter reveals the basis for differential transcript heterogeneity in multidrug-resistant J774.2 cells.

Authors:  S I Hsu; D Cohen; L S Kirschner; L Lothstein; M Hartstein; S B Horwitz
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

6.  Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells.

Authors:  Teresa Gagliano; Erica Gentilin; Katiuscia Benfini; Carmelina Di Pasquale; Martina Tassinari; Simona Falletta; Carlo Feo; Federico Tagliati; Ettore Degli Uberti; Maria Chiara Zatelli
Journal:  Endocrine       Date:  2014-08-06       Impact factor: 3.633

7.  Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells.

Authors:  S Scala; A Budillon; Z Zhan; Y S Cho-Chung; J Jefferson; M Tsokos; S E Bates
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

8.  Cloning and regulation of the rat mdr2 gene.

Authors:  P C Brown; S S Thorgeirsson; J A Silverman
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

9.  Influence of cytokines on mdr1 expression in human colon carcinoma cell lines: increased cytotoxicity of MDR relevant drugs.

Authors:  W Walther; U Stein
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

10.  Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis.

Authors:  S V Ambudkar; I H Lelong; J Zhang; C O Cardarelli; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.